Inactive Instrument

News Celestial Biolabs Limited

Equities

532871

INE221I01017

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

Celestial Biolabs Limited Appoints Dattatreya Rao as Executive Director	05-23	CI
Celestial Biolabs Limited Appoints Dattatreya Rao as Chief Executive Officer	05-23	CI
Celestial Biolabs Limited Announces Demise of Devarakonda Chidvilasa Sastri, Non-Executive Independent Director	04-23	CI
Celestial Biolabs Limited Announces Board Changes	04-22	CI
Celestial Biolabs Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	03-29	CI
Celestial Biolabs Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	14/02/23	CI
Celestial Biolabs Limited Announces Executive Appointments	30/09/22	CI
Celestial Biolabs Limited Auditor Raises 'Going Concern' Doubt	05/09/22	CI
Celestial Biolabs Limited Auditor Raises 'Going Concern' Doubt	05/09/22	CI
Celestial Biolabs Limited Auditor Raises 'Going Concern' Doubt	04/09/22	CI
Celestial Biolabs Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2022	02/09/22	CI
Celestial Biolabs Limited Announces Chief Financial Officer Changes	02/09/22	CI
Celestial Biolabs Limited Appoints Sada Naga Latha as Company Secretary and Compliance Officer	16/05/22	CI
Celestial Biolabs Limited Announces Change in Registered Office Address	26/04/22	CI
Celestial Biolabs Ltd Announces Resignation of Hardeep Choudhary as Company Secretary and Compliance Officer	20/11/19	CI
Celestial Biolabs Limited Reports Earnings Results for the First Quarter Ended June 30, 2019	14/08/19	CI
Celestial Biolabs Limited Announces Management Appointments	18/06/19	CI
Celestial Biolabs Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2019	06/06/19	CI
Celestial Biolabs Limited Reports Earnings Results for the Third Quarter Ended December 31, 2018	14/02/19	CI
Celestial Biolabs Limited Announces Unaudited Standalone Earnings Results for the Second Quarter and Six Months Ended Sept. 30, 2018	14/11/18	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Celestial Biolabs Limited

Equities

532871

INE221I01017

Summary

Filters